1 / 10

High Potency API/HPAPI Market to Reach $34.8 Billion by 2025 | Grand View Research

Increasing number of new entrants producing fast relief therapeutics in emerging countries of India and China is anticipated to boost the demand for High potency active pharmaceutical ingredients (HPAPIs) over the forecast period.

Marsh
Download Presentation

High Potency API/HPAPI Market to Reach $34.8 Billion by 2025 | Grand View Research

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. High Potency Active Pharmaceutical Ingredients Market Analysis, Size, Growth, Share & Forecast to 2025 | Grand View Research Inc. “High Potency API/HPAPI Market Size Worth $34.8 Billion By 2025” The global HPAPIs market is expected to reach USD 34.8 billion by 2025, according to a new report by Grand View Research, Inc. Increasing number of new entrants producing fast relief therapeutics in emerging countries of India and China is anticipated to boost the demand for High potency active pharmaceutical ingredients (HPAPIs) over the forecast period. In addition, supportive government regulations for commercialization and research and development of novel drug molecules are projected to drive the industry growth. Extensive capital investments required for development of production facility has lead to increase in contract manufacturing activities for HPAPIs during the forecast period. Further Key Findings From the Study Suggest: Synthetic route of High PotencyAPIs dominated the overall market in terms of revenue share as of 2016 owing to presence of large manufacturers producing these type of molecules • Biotech HPAPI segment is expected to be the fastest growing and is expected to grow at a lucrative growth ratedue torising demand for cancer drugs and fueling research and developmentactivities pertaining to it • Innovative drug market dominated the overall drug type in 2016. Generic drug segment is expected to be the fastest growing segment. The factors attributing to its growth are patent expiration of various drugs and increasing demand for the cancer treatment • Follow Us:

  2. Contact outsourcing segment is anticipated to show lucrative growth as major pharmaceuticals are focused on rigorous research and development activities for new drug development • Oncology segment heldlargest revenue share as of 2016, due to increasing demand for anti-cancerous drugs • North America HPAPIs market held the largest market share as of 2016. Growing prevalence of chronic disease patients, and established research and development infrastructure for novel drug development are factors supporting to major share of this market • Patent expiration of major drugs in North American and European countries is anticipated to fuel market growth • Asia Pacific regional market is expected to register significant growth owing to growing investments in biotechnology sector and rapidly growing oncology market • The key players in the HPAPI market includeBristol-Myers Squibb, Sigma-Aldrich Corporation, Pfizer Incand Lonza among others • Extensive research and development activities carried out by market participants is also expected to augment the market growth • Browse Details of Report @ http://www.grandviewresearch.com/industry-analysis/high-potency-active- pharmaceutical-ingredients-hpapi-market Grand View Research has segmented the High PotencyAPIsmarket on the basis of the product, manufactures, drug types, application, and region: HPAPIs Product Outlook (Revenue, USD Million, 2014 - 2025) Synthetic • Biotech • HPAPIs Manufacturers Outlook (Revenue, USD Million, 2014 - 2025) In-house • Outsourced • HPAPIs Drug Types Outlook (Revenue, USD Million, 2014 - 2025) Innovative • Generic • HPAPIs Application Outlook (Revenue, USD Million, 2014 - 2025) Follow Us:

  3. Oncology • Hormonal • Glaucoma • Others • HPAPIs Regional Outlook (Revenue, USD Million, 2014 - 2025) North America • oU.S. oCanada Europe • oGermany oUK Asia Pacific • oJapan oChina oIndia Latin America • oBrazil oMexico MEA • oSouth Africa Table of Content Chapter 1 Research Methodology 1.1 Country wise market: Base estimates 1.1.1 Global market: CAGR calculation 1.1.2 Region based segment share calculation 1.2 Research Scope & Assumptions 1.3 List of Data Sources Chapter 2 Executive Summary Follow Us:

  4. 2.1 Market Snapshot Chapter 3 HPAPI Market Variables, Trends & Scope 3.1 Market segmentation & scope 3.2 Market Driver Analysis 3.2.1 Rise in prevalence of cancer and global anti-cancer market 3.2.2 Growth of Targeted Therapy Approach 3.2.3 Increasing application of HPAPI 3.3 Market Restraint Analysis 3.3.1 Large investments and very stringent safety and handling specifications associated with production of HPAPI 3.4 Key Opportunities Prioritized 3.4.1 Key opportunities prioritized, by product 3.5 HPAPI - SWOT Analysis, By Factor (political & legal, economic and technological) 3.6 Industry Analysis - Porter’s Chapter 4 HPAPI Market: Product Estimates & Trend Analysis 4.1 HPAPI Market: Product Movement Analysis 4.2 Synthetic 4.2.1 Synthetic market, 2014 - 2025 (USD Million) 4.3 Biotech 4.3.1 Biotech market, 2014 - 2025 (USD Million) Chapter 5 HPAPI Market: Manufacturer Estimates & Trend Analysis 5.1 HPAPI Market: Manufacturer Movement Analysis 5.2 In-house 5.2.1 In-house market, 2014 - 2025 (USD Million) 5.3 Outsourced 5.3.1 Outsourced market, 2014 - 2025 (USD Million) Chapter 6 HPAPI Market: Drug Type Estimates & Trend Analysis 6.1 HPAPI Market: Drug Type Movement Analysis 6.2 Innovative 6.2.1 Innovative market, 2014 - 2025 (USD Million) 6.3 Generic 6.3.1 Generic market, 2014 - 2025 (USD Million) Chapter 7 HPAPI Market: Therapeutic Application Estimates & Trend Analysis 7.1 HPAPI Market: Therapeutic Application Movement Analysis Follow Us:

  5. 7.2 Oncology 7.2.1 Oncology market, 2014 - 2025 (USD Million) 7.3 Hormonal 7.3.1 Hormonal market, 2014 - 2025 (USD Million) 7.4 Glaucoma 7.4.1 Glaucoma market, 2014 - 2025 (USD Million) 7.5 Others 7.5.1 Others market, 2014 - 2025 (USD Million) Chapter 8 HPAPI Market: Regional Estimates & Trend Analysis, by Product, Manufacturer, Drug Type, and Therapeutic Application 8.1 HPAPI Market Share by Region, 2016& 2025 8.2 North America 8.2.1 North America HPAPI market, by country, 2014 - 2025 (USD Million) 8.2.2 North America HPAPI market, by product, 2014 - 2025 (USD Million) 8.2.3 North America HPAPI market, by manufacturer, 2014 - 2025 (USD Million) 8.2.4 North America HPAPI market, by drug type, 2014 - 2025 (USD Million) 8.2.5 North America HPAPI market, by therapeutic application, 2014 - 2025 (USD Million) 8.2.6 U.S. 8.2.6.1 U.S. HPAPI market, by product, 2014 - 2025 (USD Million) 8.2.6.2 U.S. HPAPI market, by manufacturer, 2014 - 2025 (USD Million) 8.2.6.3 U.S. HPAPI market, by drug type, 2014 - 2025 (USD Million) 8.2.6.4 U.S. HPAPI market, by therapeutic application, 2014 - 2025 (USD Million) 8.2.7 Canada 8.2.7.1 Canada HPAPI market, by product, 2014 - 2025 (USD Million) 8.2.7.2 Canada HPAPI market, by manufacturer, 2014 - 2025 (USD Million) 8.2.7.3 Canada HPAPI market, by drug type, 2014 - 2025 (USD Million) 8.2.7.4 Canada HPAPI market, by therapeutic application, 2014 - 2025 (USD Million) 8.3 Europe 8.3.1 Europe HPAPI market, by country, 2014 - 2025 (USD Million) 8.3.2 Europe HPAPI market, by product, 2014 - 2025 (USD Million) 8.3.3 Europe HPAPI market, by manufacturer, 2014 - 2025 (USD Million) 8.3.4 Europe HPAPI market, by drug type, 2014 - 2025 (USD Million) 8.3.5 Europe HPAPI market, by therapeutic application, 2014 - 2025 (USD Million) 8.3.6 Germany Follow Us:

  6. 8.3.6.1 Germany HPAPI market, by product, 2014 - 2025 (USD Million) 8.3.6.2 Germany HPAPI market, by manufacturer, 2014 - 2025 (USD Million) 8.3.6.3 Germany HPAPI market, by drug type, 2014 - 2025 (USD Million) 8.3.6.4 Germany HPAPI market, by therapeutic application, 2014 - 2025 (USD Million) 8.3.7 UK 8.3.7.1 UK HPAPI market, by product, 2014 - 2025 (USD Million) 8.3.7.2 UK HPAPI market, by manufacturer, 2014 - 2025 (USD Million) 8.3.7.3 UK HPAPI market, by drug type, 2014 - 2025 (USD Million) 8.3.7.4 UK HPAPI market, by therapeutic application, 2014 - 2025 (USD Million) 8.4 Asia Pacific 8.4.1 Asia Pacific HPAPI market, by country, 2014 - 2025 (USD Million) 8.4.2 Asia Pacific HPAPI market, by product, 2014 - 2025 (USD Million) 8.4.3 Asia Pacific HPAPI market, by manufacturer, 2014 - 2025 (USD Million) 8.4.4 Asia Pacific HPAPI market, by drug type, 2014 - 2025 (USD Million) 8.4.5 Asia Pacific HPAPI market, by therapeutic application, 2014 - 2025 (USD Million) 8.4.6 Japan 8.4.6.1 Japan HPAPI market, by product, 2014 - 2025 (USD Million) 8.4.6.2 Japan HPAPI market, by manufacturer, 2014 - 2025 (USD Million) 8.4.6.3 Japan HPAPI market, by drug type, 2014 - 2025 (USD Million) 8.4.6.4 Japan HPAPI market, by therapeutic application, 2014 - 2025 (USD Million) 8.4.7 China 8.4.7.1 China HPAPI market, by product, 2014 - 2025 (USD Million) 8.4.7.2 China HPAPI market, by manufacturer, 2014 - 2025 (USD Million) 8.4.7.3 China HPAPI market, by drug type, 2014 - 2025 (USD Million) 8.4.7.4 China HPAPI market, by therapeutic application, 2014 - 2025 (USD Million) 8.4.8 India 8.4.8.1 India HPAPI market, by product, 2014 - 2025 (USD Million) 8.4.8.2 India HPAPI market, by manufacturer, 2014 - 2025 (USD Million) 8.4.8.3 India HPAPI market, by drug type, 2014 - 2025 (USD Million) 8.4.8.4 India HPAPI market, by therapeutic application, 2014 - 2025 (USD Million) 8.5 Latin America 8.5.1 Latin America HPAPI market, by country, 2014 - 2025 (USD Million) 8.5.2 Latin America HPAPI market, by product, 2014 - 2025 (USD Million) 8.5.3 Latin America HPAPI market, by manufacturer, 2014 - 2025 (USD Million) Follow Us:

  7. 8.5.4 Latin America HPAPI market, by drug type, 2014 - 2025 (USD Million) 8.5.5 Latin America HPAPI market, by therapeutic application, 2014 - 2025 (USD Million) 8.5.6 Brazil 8.5.6.1 Brazil HPAPI market, by product, 2014 - 2025 (USD Million) 8.5.6.2 Brazil HPAPI market, by manufacturer, 2014 - 2025 (USD Million) 8.5.6.3 Brazil HPAPI market, by drug type, 2014 - 2025 (USD Million) 8.5.6.4 Brazil HPAPI market, by therapeutic application, 2014 - 2025 (USD Million) 8.5.7 Mexico 8.5.7.1 Mexico HPAPI market, by product, 2014 - 2025 (USD Million) 8.5.7.2 Mexico HPAPI market, by manufacturer, 2014 - 2025 (USD Million) 8.5.7.3 Mexico HPAPI market, by drug type, 2014 - 2025 (USD Million) 8.5.7.4 Mexico HPAPI market, by therapeutic application, 2014 - 2025 (USD Million) 8.6 MEA 8.6.1 MEA HPAPI market, by country, 2014 - 2025 (USD Million) 8.6.2 MEA HPAPI market, by product, 2014 - 2025 (USD Million) 8.6.3 MEA HPAPI market, by manufacturer, 2014 - 2025 (USD Million) 8.6.4 MEA HPAPI market, by drug type, 2014 - 2025 (USD Million) 8.6.5 MEA HPAPI market, by therapeutic application, 2014 - 2025 (USD Million) 8.6.6 South Africa 8.6.6.1 South Africa HPAPI market, by product, 2014 - 2025 (USD Million) 8.6.6.2 South Africa HPAPI market, by manufacturer, 2014 - 2025 (USD Million) 8.6.6.3 South Africa HPAPI market, by drug type, 2014 - 2025 (USD Million) 8.6.6.4 South Africa HPAPI market, by therapeutic application, 2014 - 2025 (USD Million) Chapter 9 Competitive Landscape 9.1 Strategy Framework 9.2 Market Participation 9.3 Company Profiles 9.3.1 Eli Lily and Company 9.3.1.1 Company overview 9.3.1.2 Financial performance 9.3.1.3 Product benchmarking 9.3.1.4 Strategic initiatives 9.3.2 Novartis AG 9.3.2.1 Company overview Follow Us:

  8. 9.3.2.2 Financial performance 9.3.2.3 Product benchmarking 9.3.2.4 Strategic initiatives 9.3.3 Bristol-Myers Squibb Company 9.3.3.1 Company overview 9.3.3.2 Financial performance 9.3.3.3 Product benchmarking 9.3.3.4 Strategic initiatives 9.3.4 Roche Diagnostics Ltd. 9.3.4.1 Company overview 9.3.4.2 Financial performance 9.3.4.3 Product benchmarking 9.3.4.4 Strategic initiatives 9.3.5 Sanofi 9.3.5.1 Company overview 9.3.5.2 Financial performance 9.3.5.3 Product benchmarking 9.3.5.4 Strategic initiatives 9.3.6 Hospira, Inc. 9.3.6.1 Company overview 9.3.6.2 Financial performance 9.3.6.3 Product benchmarking 9.3.6.4 Strategic initiatives 9.3.7 BASF SE 9.3.7.1 Company overview 9.3.7.2 Financial performance 9.3.7.3 Product benchmarking 9.3.7.4 Strategic initiatives 9.3.8 Covidien plc 9.3.8.1 Company overview 9.3.8.2 Financial performance 9.3.8.3 Product benchmarking 9.3.8.4 Strategic initiatives 9.3.9 Boehringer Ingelheim GmbH Follow Us:

  9. 9.3.9.1 Company overview 9.3.9.2 Financial performance 9.3.9.3 Product benchmarking 9.3.9.4 Strategic initiatives 9.3.10 Merck & Co., Inc. 9.3.10.1 Company overview 9.3.10.2 Financial performance 9.3.10.3 Product benchmarking 9.3.10.4 Strategic initiatives 9.3.11 Sigma Aldrich Corporation 9.3.11.1 Company overview 9.3.11.2 Financial performance 9.3.11.3 Product benchmarking 9.3.11.4 Strategic initiatives 9.3.12 Bayer AG 9.3.12.1 Company overview 9.3.12.2 Financial performance 9.3.12.3 Product benchmarking 9.3.12.4 Strategic initiatives 9.3.13 Carbogen Amcis AG 9.3.13.1 Company overview 9.3.13.2 Financial performance 9.3.13.3 Product benchmarking 9.3.13.4 Strategic initiatives 9.3.14 Lonza 9.3.14.1 Company overview 9.3.14.2 Financial performance 9.3.14.3 Product benchmarking 9.3.14.4 Strategic initiatives 9.3.15 Teva Pharmaceutical Industries Ltd. 9.3.15.1 Company overview 9.3.15.2 Financial performance 9.3.15.3 Product benchmarking 9.3.15.4 Strategic initiatives Follow Us:

  10. About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email:sales@grandviewresearch.com For More Information:https://www.grandviewresearch.com Follow Us:

More Related